Keyphrases
Cochlear Implant
100%
Head-and-neck Cancer
99%
Cochlea
69%
Hearing Impairment
66%
Hair Cell
65%
Head-and-neck
63%
Inner Ear
59%
Cochlear Implantation
58%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
55%
Confidence Interval
49%
Speech Perception
47%
Cochlear Implant Users
45%
Perilymph
43%
Tumor
38%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
37%
Guinea pig
36%
Hearing Aids
34%
High-risk Human Papillomavirus (HR-HPV)
32%
Older Adults
31%
Overall Survival
31%
Normal Hearing
30%
Scala Tympani
30%
Endocochlear Potential
29%
Organ of Corti
29%
Middle Ear
27%
Sudden Sensorineural Hearing Loss (SSNHL)
27%
Meta-analysis
27%
Tinnitus
26%
Pediatric
26%
Comorbidity
26%
Stria Vascularis
25%
Surgeons
25%
Gerbil
25%
Cholesteatoma
25%
Otolaryngology
24%
Quality of Life
23%
Unilateral Hearing Loss
23%
Endolymph
22%
Odds Ratio
22%
Risk Factors
22%
Chronic Rhinosinusitis
22%
Systematic Meta-analysis
21%
Supporting Cells
19%
Adjuvant Therapy
19%
Vestibular
18%
Noise Exposure
18%
Round Window
18%
Electrocochleography
17%
Otitis Media
17%
Consonants
17%
Resection
16%
Flap
16%
Hazard Ratio
16%
Pediatric Cochlear Implantation
16%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
16%
Macrophages
16%
Temporal Bone
15%
Chinchilla
15%
Laryngoscope
15%
Hearing Preservation
15%
Free Flap Reconstruction
15%
Speech Recognition
15%
Otolaryngologist
15%
United States
14%
Cancer Patients
14%
Auditory Brainstem Response
14%
Hair Cell Loss
14%
Age-related
14%
Word Recognition
13%
Regeneration
13%
Recurrent Laryngeal Nerve
13%
Neck Surgery
13%
Radiation Therapy
13%
Free Flap
13%
Noise-induced Hearing Loss
13%
Bone Resorption
13%
Pediatric Patients
13%
Compound Action Potential
13%
Staging System
12%
Vestibulo-ocular Reflex
12%
Neck Dissection
12%
Auditory Brainstem Implant
12%
Endolymphatic Hydrops
12%
Noise Effects
12%
Oral Cavity Cancer
12%
Round Window Membrane
12%
Sensory Epithelium
12%
Inner Hair Cell
12%
Mouse Model
12%
T Cells
11%
Cisplatin
11%
5-year Survival
11%
Deafness
11%
Acoustics
11%
Mongolian Gerbil
11%
Outer Hair Cell
11%
Utricle
11%
Pure-tone Average
11%
Guinea pig Cochlea
11%
Spiral Ganglion Neurons
11%
Medicine and Dentistry
Head and Neck Cancer
81%
Disease
71%
Cochlear Implant
66%
Neoplasm
64%
Neck
56%
Surgery
51%
Cochlear Implantation
47%
Hearing Impairment
46%
Cochlea
46%
Malignant Neoplasm
45%
Symptom
41%
Systematic Review
41%
Pediatrics
39%
Free Tissue Graft
38%
Oropharynx Squamous Cell Carcinoma
36%
Overall Survival
35%
Wart Virus
35%
Quality of Life
30%
Oropharyngeal Cancer
29%
Surgeon
28%
Head and Neck Squamous Cell Carcinoma
27%
Radiation Therapy
26%
Speech Production
25%
Injury
24%
Vocal Folds
24%
Recurrent Disease
24%
Odds Ratio
24%
Middle Ear
23%
Squamous Cell Carcinoma
23%
Cholesteatoma
22%
Otorhinolaryngology
22%
Meta-Analysis
21%
Chronic Rhinosinusitis
21%
Speech Perception
21%
Hazard Ratio
21%
Perilymph
20%
Round Window
19%
Adjuvant Therapy
18%
Electrocochleography
17%
Hair Cell
17%
Oral Cavity
17%
P16
16%
Scala Tympani
16%
Temporal Bone
16%
Implant
16%
Health Care Cost
16%
Diagnosis
15%
Osteolysis
15%
Oral Cancer
15%
Postoperative Complication
14%
Infection
14%
Cochlea Potential
14%
Larynx
13%
Paralysis
13%
Surgical Technique
13%
Skull Base
13%
Unilateral Hearing Loss
13%
Recurrent Laryngeal Nerve
13%
Otitis Media
13%
Clinical Trial
13%
Computer Assisted Tomography
13%
Ménière's Disease
12%
Laryngectomy
12%
Cohort Analysis
12%
COVID-19
12%
In Vitro
12%
Brainstem
11%
Cancer
11%
Vestibular Schwannoma
11%
Prevalence
11%
Pediatrics Patient
11%
T Cell
11%
Laryngeal Cancer
11%
Neck Dissection
11%
Retrospective Cohort Study
11%
Pure Tone Audiometry
11%
Magnetic Resonance Imaging
11%
Head and Neck Surgery
10%
Patient Referral
10%
Anatomy
10%
Organ of Corti
10%
Antibiotics
10%
Tertiary Care
10%
Base
10%
Combination Therapy
10%
Logistic Regression Analysis
10%
Disease Free Survival
10%
Functional Endoscopic Sinus Surgery
10%
Clinician
9%
Tracheostomy
9%
Fistula
9%
Randomized Clinical Trial
9%
Epileptic Absence
9%
Nasal Polyp
9%
Action Potential
9%
Disease Specific Survival
9%
Facial Nerve
9%
Auditory Stimulation
9%
Osteoclast
8%
Cancer Epidemiology
8%